Success Story: Advancing Artificial Intelligence Approaches for Personalized Medicine: NIW Approval Secured for a Computer Science Researcher from China
Client’s Testimonial:
"Thank you so much for your support and for preparing my NIW case."
On July 1st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor (Tenure Track) in the Field of Computer Architecture (Approval Notice).
General Field: Computer Science
Position at the Time of Case Filing: Research Data Scientist I
Country of Origin: China
State of Residence at the Time of Filing: Ohio
Approval Notice Date: July 1st, 2026
Processing Time: 1 year, 7 months, 10 days (Premium Processing Requested)
Case Summary:
The client’s work focuses on advancing state-of-the-art artificial intelligence (AI) methods to analyze human genomic, proteomic, disease, drug, and patient data for discovering new treatments and enhancing personalized medicine for complex diseases. At the time of filing, he was conducting research as a Research Data Scientist I, developing AI-driven data analysis pipelines, integrating multi-omic datasets, and creating predictive models to improve disease treatment and drug discovery. His proposed endeavor aims to enhance therapeutic efficiency and healthcare outcomes through AI-enabled insights.
Research with National Importance
His research addresses critical challenges in biomedical research and healthcare innovation. By applying AI to large-scale biological datasets, he advances predictive modeling for complex diseases, including Alzheimer’s, Parkinson’s, and chronic pain. His work supports the development of safer, cost-effective therapies and contributes to national health priorities, strengthening U.S. leadership in AI applications for biomedical science.
Academic Contributions and Recognition
At the time of filing, his record included 3 peer-reviewed journal articles (2 first-authored), 8 peer-reviewed conference papers (3 first-authored), 1 accepted journal article (first-authored), 3 conference abstracts (1 first-authored), and 4 preprints (2 first-authored). Collectively, these works have been cited a total of 47 times. He conducted at least 22 peer reviews for authoritative conferences, demonstrating recognition of his expertise by the research community. Several publications were highly cited relative to their field and year, showing that independent researchers relied on his methods and findings for advancing AI, biomedical data analysis, and personalized medicine. His research contributions include generative AI for scientific data augmentation, AI-driven drug repurposing, and interactive AI systems for clinical applications.
Expert Endorsements
Experts highlighted the significance of the client’s work and its potential to improve patient care and therapeutic development.
One expert noted:
“By effectively targeting specific receptors, his research contributes to improved patient outcomes and provides a framework for addressing urgent healthcare challenges, fostering a more responsive and innovative pharmaceutical landscape.”
This expert endorsement reinforces the national importance and practical impact of his work, complementing his publication record, citation impact, and peer review contributions.
NIW Approval and Outlook
The I-140 NIW petition was filed on November 21st, 2024, later upgraded to Premium Processing, and approved on July 1st, 2026. The approval recognized the national importance of the client’s work in computer science, particularly his contributions to AI-driven personalized medicine, multi-omic data integration, and predictive modeling for complex diseases.
This outcome supports the client’s continued efforts to develop AI-based approaches in biomedical research and personalized healthcare. We congratulate him on this approval and wish him continued success in advancing AI research for public benefit in the United States.